Maraviroc, risks and benefits: a review of the clinical literature
Author:
Affiliation:
1. University Clinic Bonn, Department of Medicine I, Sigmund-Freud-Str. 25, 53105 Bonn, Germany ; ;
Publisher
Informa Healthcare
Subject
Pharmacology (medical),General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/14740338.7.5.559
Reference24 articles.
1. Oral CCR5 inhibitors: will they make it through?
2. Access denied? The status of co-receptor inhibition to counter HIV entry
3. Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity
4. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
5. CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Toxicology of Antifungal and Antiviral Drugs;Advances in Antifungal Drug Development;2024
2. CNS Neurotoxicity of Antiretrovirals;Journal of Neuroimmune Pharmacology;2019-12-10
3. Effect of α-dextrin nanoparticles on the structure of iodine complexes with polypeptides and alkali metal halogenides, and on the mechanisms of their anti-human immunodeficiency virus and anticancer activity;Design and Development of New Nanocarriers;2018
4. Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc;International Journal of STD & AIDS;2017-01-31
5. Chemokine Receptor CCR5 Antagonist Maraviroc: Medicinal Chemistry and Clinical Applications;Current Topics in Medicinal Chemistry;2014-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3